424 related articles for article (PubMed ID: 16454628)
1. Development of a collagen-binding activity assay as a screening test for type II von Willebrand disease in dogs.
Sabino EP; Erb HN; Catalfamo JL
Am J Vet Res; 2006 Feb; 67(2):242-9. PubMed ID: 16454628
[TBL] [Abstract][Full Text] [Related]
2. Measurement of von Willebrand factor-specific mRNA and release and storage of von Willebrand factor from endothelial cells of dogs with type-I von Willebrand's disease.
Meinkoth JH; Meyers KM
Am J Vet Res; 1995 Dec; 56(12):1577-85. PubMed ID: 8599517
[TBL] [Abstract][Full Text] [Related]
3. Von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: a 15-year journey.
Favaloro EJ
Semin Thromb Hemost; 2002 Apr; 28(2):191-202. PubMed ID: 11992242
[TBL] [Abstract][Full Text] [Related]
4. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
[TBL] [Abstract][Full Text] [Related]
5. Plasma von Willebrand factor antigen concentration as a predictor of von Willebrand's disease status in German Wirehaired Pointers.
Brooks M; Raymond S; Catalfamo J
J Am Vet Med Assoc; 1996 Sep; 209(5):930-3. PubMed ID: 8790543
[TBL] [Abstract][Full Text] [Related]
6. [Application of collagen-binding assay for von Willebrand disease].
Zhou J; Jia YQ; Jiang H; Yang YM; Deng CQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):126-9. PubMed ID: 14981837
[TBL] [Abstract][Full Text] [Related]
7. Collagen binding assay for von Willebrand factor (VWF:CBA): detection of von Willebrands Disease (VWD), and discrimination of VWD subtypes, depends on collagen source.
Favaloro EJ
Thromb Haemost; 2000 Jan; 83(1):127-35. PubMed ID: 10669166
[TBL] [Abstract][Full Text] [Related]
8. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R
Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
[TBL] [Abstract][Full Text] [Related]
9. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
[TBL] [Abstract][Full Text] [Related]
10. Effect of desmopressin on von Willebrand factor multimers in Doberman Pinschers with type 1 von Willebrand disease.
Callan MB; Giger U; Catalfamo JL
Am J Vet Res; 2005 May; 66(5):861-7. PubMed ID: 15938072
[TBL] [Abstract][Full Text] [Related]
11. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H
Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
[TBL] [Abstract][Full Text] [Related]
12. Discrimination of von Willebrands disease (VWD) subtypes: direct comparison of von Willebrand factor:collagen binding assay (VWF:CBA) with monoclonal antibody (MAB) based VWF-capture systems.
Favaloro EJ; Henniker A; Facey D; Hertzberg M
Thromb Haemost; 2000 Oct; 84(4):541-7. PubMed ID: 11057847
[TBL] [Abstract][Full Text] [Related]
13. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
14. Plasma von Willebrand factor changes during various reproductive cycle stages in mixed-breed dogs with normal von Willebrand factor and in Doberman pinschers with type-I von Willebrand's disease.
Moser J; Meyers KM; Russon RH; Reeves JJ
Am J Vet Res; 1998 Jan; 59(1):111-8. PubMed ID: 9442254
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory features of a severe form of von Willebrand disease in Shetland sheepdogs.
Raymond SL; Jones DW; Brooks MB; Dodds WJ
J Am Vet Med Assoc; 1990 Nov; 197(10):1342-6. PubMed ID: 2266049
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
Turecek PL; Siekmann J; Schwarz HP
Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
[TBL] [Abstract][Full Text] [Related]
17. Detection of von Willebrand disorder and identification of qualitative von Willebrand factor defects. Direct comparison of commercial ELISA-based von Willebrand factor activity options.
Favaloro EJ
Am J Clin Pathol; 2000 Oct; 114(4):608-18. PubMed ID: 11026108
[TBL] [Abstract][Full Text] [Related]
18. Severe, recessive von Willebrand's disease in German Wirehaired Pointers.
Brooks M; Raymond S; Catalfamo J
J Am Vet Med Assoc; 1996 Sep; 209(5):926-9. PubMed ID: 8790542
[TBL] [Abstract][Full Text] [Related]
19. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease.
de Romeuf C; Mazurier C
Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782
[TBL] [Abstract][Full Text] [Related]
20. Epidemiologic features of von Willebrand's disease in Doberman pinschers, Scottish terriers, and Shetland sheepdogs: 260 cases (1984-1988).
Brooks M; Dodds WJ; Raymond SL
J Am Vet Med Assoc; 1992 Apr; 200(8):1123-7. PubMed ID: 1607320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
